(Q33867000)

29 July 2017

1 reference

title

Stem cell transplantation for treatment of severe autoimmune diseases: current status and future perspectives (English)

1 reference

29 July 2017

Jantunen E

1

1 reference

29 July 2017

Myllykangas-Luosujärvi R

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

Bone Marrow Transplantation

29 July 2017

published in

1 reference

29 July 2017

volume

25

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

351-356

1 reference

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Haemopoietic stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Stem cell transplantation--a treatment for severe rheumatic diseases?--A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Regression of adjuvant-induced arthritis in rats following bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Long-term observations of autoimmune-prone mice treated for autoimmune disease by allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long-term remission of coincidental Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Autologous PBPCT in a patient with lymphoma and Sjögren's syndrome: complete remission of lymphoma without control of the autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

A phase 1 study to address the safety and efficacy of granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

Risk factors for severe hemorrhagic cystitis following BMT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Autologous bone-marrow transplantation for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Remission and immune reconstitution after T-cell-depleted stem-cell transplantation for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Hematopoietic stem-cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for Felty's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

A randomised, blinded, placebo-controlled, dose escalation study of the tolerability and efficacy of filgrastim for haemopoietic stem cell mobilisation in patients with severe active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702152

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1702152

1 reference

Dimensions Publication ID

29 July 2017

1040090655

0 references

1 reference